Evidence map›Paper›PMID 7613467›Full record

ArticleProtein science : a publication of the Protein Society1995

Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.

W T Lowther, P Majer, B M Dunn

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 31 citations in OpenAlex.

  1. Active site specificity of plasmepsin II.Protein science : a publication of the Protein Society · 1999
    Article
  2. Molecular and biotechnological aspects of microbial proteases.Microbiology and molecular biology reviews : MMBR · 1998
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

W T LowtherDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville 32610-0245, USA.
P Majer
B M Dunn
University of Florida · USNational Cancer Institute · US

Funding

MECHANISMS OF PEPSIN CATALYSIS &INHIBITIONR01DK018865 · NIDDK · UNIVERSITY OF FLORIDA · PI DUNN, BEN M. · 1986 to 2001
$394k
NIDDK NIH HHS DK18865
6 · The paper itself

Abstract

Rhizopuspepsin and other fungal aspartic proteinases are distinct from the mammalian enzymes in that they are able to cleave substrates with lysine in the P1 position. Sequence and structural comparisons suggest that two aspartic acid residues, Asp 30 and Asp 77 (pig pepsin numbering), may be responsible for generating this unique specificity. Asp 30 and Asp 77 were changed to the corresponding residues in porcine pepsin, Ile 30 and Thr 77, to create single and double mutants. The zymogen forms of the wild-type and mutant enzymes were overexpressed in Escherichia coli as inclusion bodies. Following solubilization, denaturation, refolding, activation, and purification to homogeneity, structural and kinetic comparisons were made. The mutant enzymes exhibited a high degree of structural similarity to the wild-type recombinant protein and a native isozyme. The catalytic activities of the recombinant proteins were analyzed with chromogenic substrates containing lysine in the P1, P2, or P3 positions. Mutation of Asp 77 resulted in a loss of 7 kcal mol-1 of transition-state stabilization energy in the hydrolysis of the substrate containing lysine in P1. An inhibitor containing the positively charged P1-lysine side chain inhibited only the enzymes containing Asp 77. Inhibition of the Asp 77 mutants of rhizopuspepsin and several mammalian enzymes was restored upon acetylation of the lysine side chain. These results suggest that an exploitation of the specific electrostatic interaction of Asp 77 in the active site of fungal enzymes may lead to the design of compounds that preferentially inhibit a variety of related Candida proteinases in immunocompromised patients.

Indexed as

Protein EngineeringAmino Acid SequenceAnimalsAspartic AcidAspartic Acid EndopeptidasesBase SequenceCircular DichroismComputer GraphicsEnzyme InhibitorsEnzyme PrecursorsHydrogen BondingHydrogen-Ion ConcentrationKineticsModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedAspartic AcidAspartic Acid EndopeptidasesEnzyme InhibitorsEnzyme PrecursorsOligopeptidesPepsin ARecombinant Proteinsrhizopuspepsin

Identifiers

PMID7613467
PMCPMC2143106
OpenAlexW2090196107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.